Regulatory Rapporteur November 2005
Volume 2 Issue 11
In This Issue
- Focus on promotional activities. What are the rules?
- Mutual Recognition and Decentralised Procedures - interview with Shirley Norton
- 10 years of EMEA CNS Medicines - Antipsychotic treatments
Please login to view member only articles. Non-members may download the public articles.
| Title | Download | Category | Size | File |
|---|---|---|---|---|
| Regulatory Rapporteur November 2005 | Members | Full Issue | 2MB | |
| Worldwide survey on national controls of pharmaceutical advertising and promotion | Public | 202KB | ||
| 10 Years of EMEA CNS Medicines | Members | 440KB | ||
| Beware the ads of March? | Members | 103KB | ||
| EU Regulatory Intelligence: Updates October 2005 | Members | 150KB | ||
| Mutual Recognition and Decentralised Procedures | Members | 295KB | ||
| New Medicines Legislation – Working with the MHRA | Members | 169KB | ||
| Sales and marketing practices for prescription medicines: New rules in a new environment. | Members | 255KB | ||
| The Exchange: Co-ordinated by Origin Pharmaceutical Services Limited | Members | 156KB | ||
| The history of medical device regulations | Members | 177KB | ||
| The Spanish Code of Practice for the Promotion of Medicines | Members | 613KB |